Skip to content
Diabetes & Weight — GLP-1 receptor agonistsATC A10BJ06

Semaglutide

Prescription onlyWHO essential medicine

Weekly injection (or daily pill) for diabetes and weight loss.

Starts working
Appetite falls within days; full effect over months
Half-life
About 1 week
In use since
2017
Pregnancy
Usually avoided

Overview

Semaglutide is a GLP-1 medicine sold as Ozempic for type 2 diabetes, Wegovy for weight management and Rybelsus as a daily tablet. It lowers blood sugar, reduces appetite, causes about 15% average weight loss at the obesity dose and cuts heart attacks and strokes in people with heart disease.

How it works

Copies a gut hormone that boosts insulin after meals, slows the stomach and makes you feel full.

Semaglutide belongs to the GLP-1 receptor agonists. How GLP-1 receptor agonists work: mimic a gut hormone that boosts insulin after meals, lowers glucagon, slows the stomach and reduces appetite in the brain.

Uses

  • Type 2 diabetes
  • Obesity and overweight with health problems
  • Reducing heart attack and stroke risk
  • Kidney disease in type 2 diabetes
  • MASH (fatty liver inflammation)

Available as: weekly pen injection, daily tablet.

Typical dose

Adults
Ozempic: 0.25 mg weekly, increased monthly to 0.5–2 mg. Wegovy: increased over 16 weeks to 2.4 mg weekly. Rybelsus: 3 mg rising to 7–14 mg daily, on an empty stomach with a sip of water.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Reflux
  • Tiredness

Serious — get medical help

Uncommon, but need prompt attention

  • Pancreatitis
  • Gallstones
  • Dehydration and kidney injury from vomiting
  • Worsening diabetic eye disease with rapid sugar falls
  • Optic nerve damage (NAION, very rare)
  • Aspiration during anaesthesia

Warnings

  • Increase dose slowly to limit nausea
  • Not with a personal or family history of medullary thyroid cancer or MEN2
  • Tell your anaesthetist before surgery
  • Avoid unregulated 'compounded' or online versions
  • Weight usually returns if stopped

Interactions

  • Insulin and sulfonylureas — hypos (doses often reduced)
  • Oral medicines — absorption can change because the stomach slows
  • Oral contraceptives — use extra protection with tirzepatide; less concern with semaglutide
Check Semaglutide against your own medicines

Pregnancy and breastfeeding

Usually avoided

Stop at least 2 months before trying to conceive.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Ozempic, Wegovy, Rybelsus
United Kingdom
Ozempic, Wegovy, Rybelsus
India
Ozempic, Wegovy, Rybelsus
Australia
Ozempic, Wegovy

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

  1. 2017

    Ozempic approved in the US.

  2. 2021

    Wegovy approved for weight management.

  3. 2023

    SELECT trial: 20% fewer heart attacks, strokes and cardiovascular deaths in people with obesity and heart disease.

  4. 2025

    WHO adds GLP-1 medicines to its Essential Medicines List; an oral Wegovy pill is approved in the US.

  5. 2026

    The key patent expires in India in March; dozens of generic brands launch at a fraction of the original price.

GLP-1 research traces back to the venom of the Gila monster lizard, which gave the first GLP-1 drug, exenatide.

Common questions

Will I keep the weight off if I stop?

In trials most people regained around two-thirds of the lost weight within a year of stopping.

Is Ozempic the same as Wegovy?

Same medicine; Wegovy is licensed for weight and goes up to a higher dose.

Do I need a prescription for Semaglutide?

Yes — Semaglutide is prescription-only in most countries.

Can I take Semaglutide during pregnancy?

Usually avoided. Stop at least 2 months before trying to conceive. Always check with a doctor or midwife.

How quickly does Semaglutide work?

Appetite falls within days; full effect over months.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.